Hope for people 
that have none

We use technology to reduce inequity in healthcare

innovative and affordable medical technologies reducing critical healthcare inequalities for millions worldwide

first-of-its-kind adjustable, minimally invasive percutaneous intervention to replace surgical Pulmonary Artery Banding (PAB)

The Problem

Cardiovascular Disease (CVD) is the leading cause of death worldwide

#1 CAUSE OF DEATH

this isn’t a surprise. cardiovascular disease is the leading cause of death

AFFORDABILITY

low and middle income countries now experience the highest prevalence and mortality rates of CVDs

SCALE

31% of global deaths are a result of CVD

EFFECT

one person dies every 36 seconds in the US from CVD 

126.9 million
Between 2015 and 2018, 126.9 million American
adults had some form of CVD
$363.4 billion
Between 2016 to 2017, direct and indirect costs of
total CVD were $363.4 billion*
*($216.0 billion in direct costs and $147.4 billion in lost productivity/mortality)

OF CVD DEATHS OCCUR IN THE DEVELOPING WORLD

cases of total CVD in 2019—nearly doubled from 271 million in 1990

of the world’s population does not have access to CVD treatment

structural heart and left heart disease

Our Solution

the patented HeartPoint Global Implant System (HPGS)

FIRST-OF-ITS-KIND

adjustable, minimally invasive percutaneous intervention to replace surgical Pulmonary Artery Banding (PAB)

APPLICATION

we can treat more than 10 cardio-vascular diseases using the HeartPoint Global Implant System (HPGS)

MINIMALLY INVASIVE

solutions for both juvenile and adult congenital heart defect patients and congestive heart disease patients

RECOVERY

excessive pulmonary artery blood flow is reduced and the normal function of the heart-lung system is partially or fully restored

Patented, safer and affordable solutions that de-risk cardiovascular treatment

1

ADJUSTABLE

HPGS allows adjustments of pressure up and/or down during or after the initial intervention to improve the structural flow of the heart-lung system.

2

SAFER

HPGS dramatically reduces mortality risk, complication risk, and the suffering associated with surgeries or transplants.

3

MINIMALLY-INVASIVE

HPGS dramatically reduces recovery times and potential complications during and after the procedure.

4

QUALITY-OF-LIFE

HPGS delivers improvements by 2 levels in cardiac function based upon the NYC Heart Association scale.

5

10+ INDICATIONS

HPGS continuously expands the spectrum of heart diseases it can treat.

The first and only minimally invasive adjustable structural heart system that brings affordability, accessibility, and the potential to save millions of lives in the developed and developing world

Total Available Market

Serviceable Available Market

Serviceable Obtainable Market

Visionary Founding Team

with extensive experience in business and operations

Seth Bogner

Chairman & CEO

USA, Israel

Hanna Ilesan, PhD

COO

Israel, Ireland

Brian Seidman

Managing Director

Ireland, USA

Mooneerah Karoo

CFO

Mauritius, Ireland

Cathal Brennan

Head of Reg. Affairs

Ireland

Noel Manicle

Head of Quality

Ireland

Yaniv Marmur

CTO

Israel

John Burke

Head of R&D

Ireland

Lia Bruselovky

Lead PM

Ireland

Medical Leadership

with the most relevant cardiovascular, healthcare, and technology experience

Dr. David Planer

Chief Interventional Cardiologist Hadassah Medical Center, Jerusalem

Israel

Prof. Dr. Paul R. Vogt

Chief of Cardiac Surgery Zurich University Hospital

Switzerland

Prof. Dr. Christian Jux

Head of the Department of Pediatric Cardiology, University Hospital Giessen

Germany

Dr. Robert Kelly

Consultant Cardiologist at Beacon Hospital, Dublin

Ireland

Dr. Glib Iemets

Professor of Pediatric Cardiac Surgery, Director of Ukrainian Children’s Cardiac Center, Kiev

Ukraine

Dr. Gabby Elbaz-Greener

Interventional Cardiologist & Surgeon, Hadassah Medical Center, Jerusalem

Israel

Prof. Dr. Sabine Däbritz

Specialist in Cardiac and thoracic Vascular Surgery, Hirslanden Private Hospital Group, Zurich

Switzerland

Prof. Emeritus Dr. Rolf Jenni

Senior Consultant for Zurich University Hospital, Inventor, Zurich

Switzerland

Contact Us

HeartPoint Global Inc. is a company with offices in US, Ireland and Israel. 

Get in touch

Address:

One Alhambra Plaza Coral Gables FL 33134

Phone:

+1 786 320 8038

Follow us: